Altre lingue Tianjin Development Holdings Limited

Azioni

882 HK0882007260

Mercato chiuso - Hong Kong S.E. Altri mercati azionari 10:08:22 10/05/2024			Variaz. 5gg	Var. 1 gen.
1,88 ^HKD	+1,08%		0,00%	+27,89%

27/03	Il presidente di Tianjin Development si dimette; nominato il successore	MT
27/03	Tianjin Development Holdings Limited annuncia cambiamenti nel Consiglio di Amministrazione	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Tianjin Development Posts 77% Profit Jump for 2023	26/04
Tianjin Development’s Chairman Steps Down; Successor Named	27/03
Tianjin Development Holdings Limited Announces Board Changes	27/03
Tianjin Development Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 29 July 2024	27/03
Tianjin Development Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Tianjin Lisheng Pharmaceutical's 2023 Profit Surges on Gains from Asset Disposals; Shares Jump 4%	22/03
Tianjin Development Holdings Expects Up to 80% Jump in 2023 Profit	14/03
Tianjin Development Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	13/03
Lisheng Pharmaceutical Buys 65% Stake in Qingchun Kangyuan Pharmaceutical for 137 Million Yuan; Shares Up 3%	02/01
Tianjin Arm Lisheng Pharmaceutical To Buy Chinese Medicine Firm Jiangxi Qingchun Kangyuan	14/12
Tianjin Lisheng Pharma Setting Up Venture Capital Fund	12/12
Tianjin Development to Vote Dec. 5 on Lisheng Pharma's Sale of Tianjin Pharmaceutical Finance Stake	10/11
Tianjin Development Holdings Limited Announces Board Changes	29/09/23
Tianjin Development Holdings Limited(SEHK:882) dropped from S&P Global BMI Index	18/09/23
Tianjin Development Holdings' H1 Attributable Profit Grows	30/08/23
Tianjin Development Holdings Limited Declares Interim Dividend for the Six Months Ended 30 June 2023, Payable on 30 October 2023	30/08/23
Tianjin Development Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23
Lisheng Pharmaceutical's H1 Attributable Profit Jumps	25/08/23
China Evergrande sucht Gläubigerschutz in den USA	18/08/23
Lisheng Pharmaceutical Subscribes for 20 Million Yuan Wealth Management Product	02/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Tianjin Development Holdings Limited

Azioni

882

HK0882007260

Altre lingue

Filtri